Literature DB >> 17524786

Abnormal foveal avascular zone in nanophthalmos.

Mark K Walsh1, Morton F Goldberg.   

Abstract

PURPOSE: To evaluate the foveas of nanophthalmic patients.
DESIGN: Retrospective observational case series.
METHODS: Four nanophthalmic patients examined between April 2005 and April 2006 were included. Visual acuity (VA), refractive correction, axial length, corneal diameter, presence or lack of foveal light reflex, as well as fluorescein angiograms (FAs), and optical coherence tomography (OCT) scans of the maculae were evaluated.
RESULTS: None of the eight eyes had a foveal light reflex, corresponding to lack of a normal foveal pit on OCT. Fluorescein angiography showed no normal foveal avascular zones; all were either completely absent or small and rudimentary.
CONCLUSIONS: Nanophthalmic patients rarely have best-corrected visual acuity (BCVA) better than 20/40 at any point in their lives, even with an absence of known complications, such as uveal effusion or glaucoma. In many patients, this visual deficiency may correspond to an absent or rudimentary foveal avascular zone and lack of a normal foveal pit.

Entities:  

Mesh:

Year:  2007        PMID: 17524786     DOI: 10.1016/j.ajo.2007.01.051

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  19 in total

1.  Clinical features of posterior microphthalmic and nanophthalmic eyes.

Authors:  Jing-Jing Liu; Yi-Ye Chen; Xiang Zhang; Pei-Quan Zhao
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

2.  Foveal avascular zone and its relationship to foveal pit shape.

Authors:  Toco Y P Chui; Zhangyi Zhong; Hongxin Song; Stephen A Burns
Journal:  Optom Vis Sci       Date:  2012-05       Impact factor: 1.973

3.  A 61-year-old man with cystoid macular edema and chorioretinal folds after cataract surgery.

Authors:  Andrew Lee; Sandra R Montezuma
Journal:  Digit J Ophthalmol       Date:  2017-08-29

4.  Foveal avascular zone area measurements with optical coherence tomography angiography in patients with nanophthalmos.

Authors:  Ali Demircan; Ceren Yesilkaya; Cigdem Altan; Zeynep Alkin; Dilek Yasa; Ebru Demet Aygit; Damla Bektasoglu
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

5.  Novel membrane frizzled-related protein gene mutation as cause of posterior microphthalmia resulting in high hyperopia with macular folds.

Authors:  Rosemarie A Wasmann; Jolien S Klein Wassink-Ruiter; Olof H Sundin; Elisa Morales; Joke B G M Verheij; Jan Willem R Pott
Journal:  Acta Ophthalmol       Date:  2013-06-07       Impact factor: 3.761

6.  Autosomal-recessive posterior microphthalmos is caused by mutations in PRSS56, a gene encoding a trypsin-like serine protease.

Authors:  Andreas Gal; Isabella Rau; Leila El Matri; Hans-Jürgen Kreienkamp; Susanne Fehr; Karim Baklouti; Ibtissem Chouchane; Yun Li; Monika Rehbein; Josefine Fuchs; Hans C Fledelius; Kaj Vilhelmsen; Daniel F Schorderet; Francis L Munier; Elsebet Ostergaard; Debra A Thompson; Thomas Rosenberg
Journal:  Am J Hum Genet       Date:  2011-03-11       Impact factor: 11.025

7.  Visual insignificance of the foveal pit: reassessment of foveal hypoplasia as fovea plana.

Authors:  Michael F Marmor; Stacey S Choi; Robert J Zawadzki; John S Werner
Journal:  Arch Ophthalmol       Date:  2008-07

8.  Developmental basis of nanophthalmos: MFRP Is required for both prenatal ocular growth and postnatal emmetropization.

Authors:  Olof H Sundin; Sharola Dharmaraj; Imran A Bhutto; Takuya Hasegawa; D Scott McLeod; Carol A Merges; Eduardo D Silval; Irene H Maumenee; Gerard A Lutty
Journal:  Ophthalmic Genet       Date:  2008-03       Impact factor: 1.803

9.  Assessing the spatial relationship between fixation and foveal specializations.

Authors:  Melissa A Wilk; Adam M Dubis; Robert F Cooper; Phyllis Summerfelt; Alfredo Dubra; Joseph Carroll
Journal:  Vision Res       Date:  2016-06-18       Impact factor: 1.886

10.  Glaucoma in a patient with nanophthalmos.

Authors:  Kouros Nouri-Mahdavi; Naveed Nilforushan; Mohammad-Reza Razeghinejad; Heydar Amini; Shamira A Perera
Journal:  J Ophthalmic Vis Res       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.